SEARCH

SEARCH BY CITATION

References

  • 1
    Davies JNP, Knowelden J, Wilson BA. Incidence rates of cancer in Kyondondo County, Uganda 1954–1960. J Nat Cancer Inst 1965; 35: 789821.
  • 2
    Kampala City Council. District profile. Available at www.kcc.go.ug/downloads/district_profile.pdf [last accessed 31 Aug 2009].
  • 3
    Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S. Trends in cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 2000; 82: 158592.
  • 4
    PercyC, Van HoltenV, MuirC, eds. International classification of diseases for oncology, 2nd edn. Geneva, Switzerland: World Health Organization, 1990.
  • 5
    Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International classification of diseases for oncology, 3rd edn. Geneva, Switzerland: World Health Organization, 2000.
  • 6
    World Health Organization. International statistical classification of diseases and related health problems, 10th revision. Geneva, Switzerland: World Health Organization, 1992.
  • 7
    Doll R, Smith PG. Comparison between registries: age-standardized rates. In: WaterhouseJAH, MuirCS, ShanmugaratnamK, PowellJ, PeachamD, WhelanS, eds.Cancer incidence in five continents, vol. IV (IARC scientific publication no. 42). Lyon: IARC, 1982. 6715.
  • 8
    Parkin DM, Wabinga H, Nambooze S. Completeness in an African cancer registry. Cancer Causes Control 2001; 12: 14752.
  • 9
    ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds.Cancer incidence in five continents, vol. VII (IARC scientific publication no. 143). Lyon, France: IARC, 1997.
  • 10
    ParkinDM, WhelanSL, FerlayJ, TeppoL, ThomasDB, eds.Cancer incidence in five continents, vol. VIII (IARC scientific publication no. 155). Lyon, France: IARC, 2002.
  • 11
    CuradoMP, EdwardsB, ShinHR, StormH, FerlayJ, HeanueM, BoyleP, eds.Cancer incidence in five continents, vol. IX (IARC scientific publication no. 160). Lyon, France: IARC, 2007.
  • 12
    Unwin N, Setel P, Rashid S, Mugusi F, Mbanya JC, Kitange H, Hayes L, Edwards R, Aspray T, Alberti KG. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull World Health Organ 2001; 79: 94753.
  • 13
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002. Cancer incidence, mortality and prevalence worldwide (IARC cancerbase no. 5), version 2.0. Lyon, France: IARC, 2004.
  • 14
    Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer 1971; 28: 313.
  • 15
    World Health Organisation. WHO global infobase, Uganda, 2009. Available at http://apps.who.int/infobase/report.aspx?rid=114&iso=UGA&ind=TOB [last accessed 31 Aug 2009].
  • 16
    ShafeyO, DolwickS, GuindonGE, eds. Tobacco control country profiles, 2nd edn. The American Cancer Society, World Health Organization, and International Union Against Cancer, American Cancer Society, Atlanta, Ga. 2003.
  • 17
    Jaskiewicz K. Oesophageal carcinoma: cytopathology and nutritional aspects in aetiology. Anticancer Res 1989; 9: 184752.
  • 18
    IARC.IARC monographs on the evaluation of carcinogenic risks to humans, vol. 56: some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, France: IARC, 1993.
  • 19
    Newton R, Ziegler JL, Casabonne D, Carpenter L, Gold BD, Owens M, Beral V, Mbidde E, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Uganda Kaposi's Sarcoma Study Group. Helicobacter pylori and cancer among adults in Uganda. Infect Agent Cancer 2006; 1: 5.
  • 20
    Nakwagala FN, Kagimu MM. Hepatitis B virus and HIV infections among patients in Mulago hospital. East Afr Med J 2002; 79: 6872.
  • 21
    Sebunya TK, Yourtee DM. Aflatoxigenic Aspergilli in foods and feeds in Uganda. J Food Quality 1990; 13: 97197.
  • 22
    Ocama P, Nambooze S, Opio CK, Shiles MS, Wabinga HR, Kirk GD. Trends in the incidence of primary liver cancer in Central Uganda, 1960–1980 and 1991–2005. Br J Cancer 2009; 100: 799802.
  • 23
    Mbulaiteye SM, Parkin DM, Rabkin CS. Epidemiology of AIDS related malignancies an international perspective. Hematol Oncol Clin North Am 2003; 17: 67396.
  • 24
    Newton R, Bousarghin L, Ziegler J, Casabonne D, Beral V, Mbidde E, Carpenter L, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Touzé A, et al, Uganda Kaposi's Sarcoma Study Group. Human papillomaviruses and cancer in Uganda. Eur J Cancer Prev 2004; 13: 11318.
  • 25
    Bosch FX, Burchell AN, Schiffman M, Giuliano AR, de Sanjose S, Bruni L, Tortolero-Luna G, Kjaer SK, Muñoz N. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008; 26 ( Suppl 10): K116.
  • 26
    IARC.IARC monograph on the evaluation of carcinogenic risks to humans, vol. 70: Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. Lyon, France: IARC, 1998.
  • 27
    Chang Y, Ziegler J, Wabinga H, Katangole-Mbidde E, Boshoff C, Schultz T, Whitby D, Maddelena D, Jaffe HW, Weiss RA, Moore PS. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Int Med 1996; 156: 2024.
  • 28
    Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 9258.
  • 29
    Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, et al. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet 1996; 348: 11338.
  • 30
    Parkin DM, Wabinga H, Nambooze S, Wabwire-Mangen F. AIDS-related cancers in Africa: maturation of the epidemic in Uganda. AIDS 1999; 13: 256370.
  • 31
    Uganda AIDS Commission. National HIV/AIDS strategic plan for Uganda 2007/08 to 2011/12. Kampala, Uganda: Uganda AIDS Commission, 2008.
  • 32
    Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 1995; 345: 6956.
  • 33
    Newton R. A review of the aetiology of squamous cell carcinoma of the conjunctiva. Br J Cancer 1996; 74: 151113.
  • 34
    Dodge OG, Owor R, Templeton AC. Tumours of the male genitalia. In: TempletonAC, ed. Tumours in a tropical country: recent results in cancer control, No 41. Berlin: Springer, 1973: 13244.
  • 35
    Brocklehurst P, Volmink J. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev 2002; 2: CD003510.
  • 36
    Parkin DM, Garcia-Giannoli H, Raphaël M, Martin A, Katangole-Mbidde E, Wabinga H, Ziegler J. Non-Hodgkin lymphoma in Uganda: a case–control study. AIDS 2000; 14: 292936.
  • 37
    Kyalwazi SK. Carcinoma of the penis: a review of 153 patients admitted to Mulago Hospital, Kampala, Uganda. East Afr Med J 1966; 43: 41525.